Oseltamivir Phosphate Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Oseltamivir Phosphate Capsule (capsule) from Genentech, Inc with status To Be Discontinued. The shortage was first posted on 07/08/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Genentech, Inc
- Package NDC
- 0004-0802-85
- Dosage Form
- Capsule
- Presentation
- Tamiflu, Capsule, 30 mg (NDC 0004-0802-85)
- Initial Posting
- 07/08/2025
- Revised Date